2008
DOI: 10.2176/nmc.48.401
|View full text |Cite
|
Sign up to set email alerts
|

Craniocervical Paraganglioma With Numerous Pulmonary Metastases -Case Report-

Abstract: A 28-year-old man presented with a rare craniocervical paraganglioma with multiple pulmonary metastases manifesting as hearing disturbance, hoarseness, and dysphagia in February 2003. Magnetic resonance imaging depicted a large jugular foramen tumor extending to the deep cervical region. Chest computed tomography revealed numerous small pulmonary nodules. The jugular tumor was totally resected immediately after preoperative embolization. Histological examination revealed paraganglioma. Localized irradiation (5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…The most used regimen combines cyclophosphamide, vincristine, and dacarbazine (CVD) and can provide tumor regression up to 50% (14). Other regimens have been tested, including gemcitabine alone or with docetaxel (15,16) or paclitaxel (17) and etoposide-cisplatin (18); however, treatment experience with all these regimens is limited and toxicities are severe, whereas quality of life is an important objective in patients whose survival may be long. Sunitinib appears to be a promising treatment in this malignancy based on a few case reports (19,20).…”
Section: Discussionmentioning
confidence: 99%
“…The most used regimen combines cyclophosphamide, vincristine, and dacarbazine (CVD) and can provide tumor regression up to 50% (14). Other regimens have been tested, including gemcitabine alone or with docetaxel (15,16) or paclitaxel (17) and etoposide-cisplatin (18); however, treatment experience with all these regimens is limited and toxicities are severe, whereas quality of life is an important objective in patients whose survival may be long. Sunitinib appears to be a promising treatment in this malignancy based on a few case reports (19,20).…”
Section: Discussionmentioning
confidence: 99%
“…Chemotherapy has been reported to be unsuccessful. 13 Secreting paragangliomas need α-and β-adrenergic blockade prior to surgery. 3 Radiopharmaceutical treatment such as I-mIBG (I-metaiodobenzylguanidine) either alone or in combination with chemotherapy has been tried in a few cases.…”
mentioning
confidence: 99%